ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för axitinib. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

15 träffar

Bibliografisk träff 2012-07-18

Axitinib targeted cancer stemlike cells to enhance efficacy of chemotherapeutic drugs via inhibiting the drug transport function of ABCG2.

Wang F, Mi YJ, Chen XG, Wu XP, Liu Z, Chen SP, Liang YJ, Cheng C, To KK, Fu LW.

Mol Med · research support, non-u.s. gov't; research-article; journal article · DOI 10.2119/molmed.2011.00444

Bibliografisk träff 2012-06-25

Concise drug review: pazopanib and axitinib.

van Geel RM, Beijnen JH, Schellens JH.

Oncologist · research support, non-u.s. gov't; research-article; review; journal article · DOI 10.1634/theoncologist.2012-0055

Bibliografisk träff 2012-06-18

Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatment.

Grünwald V, Merseburger AS.

Onco Targets Ther · review-article; journal article · DOI 10.2147/ott.s23273

Bibliografisk träff 2012-06-01

Combined vaccine+axitinib therapy yields superior antitumor efficacy in a murine melanoma model.

Bose A, Lowe DB, Rao A, Storkus WJ.

Melanoma Res · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1097/cmr.0b013e3283538293

Bibliografisk träff 2012-06-01

Axitinib (Inlyta) for advanced renal cell carcinoma.

Författaruppgift saknas

Med Lett Drugs Ther · journal article

Bibliografisk träff 2012-06-01

[Therapeutic effect of axitinib and 5-FU in nude mice bearing human colon cancer xenograft].

Zhao J, Zhao T, Xie F, He B.

Nan Fang Yi Ke Da Xue Xue Bao · research support, u.s. gov't, non-p.h.s.; journal article

Bibliografisk träff 2012-05-27

Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers.

Pithavala YK, Chen Y, Toh M, Selaru P, LaBadie RR, Garrett M, Hee B, Mount J, Ni G, Klamerus KJ, Tortorici MA.

Cancer Chemother Pharmacol · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1007/s00280-012-1888-9

Bibliografisk träff 2012-05-01

Comprehensive overview of axitinib development in solid malignancies: focus on metastatic renal cell carcinoma.

Carmichael C, Lau C, Josephson DY, Pal SK.

Clin Adv Hematol Oncol · review; journal article; research support, n.i.h., extramural

Bibliografisk träff 2012-03-01

Systemic therapy in renal cell carcinoma: advancing paradigms.

Posadas EM, Figlin RA.

Oncology (Williston Park) · review; journal article

Bibliografisk träff 2012-01-17

Pharmacokinetic evaluation of axitinib.

Patson B, B Cohen R, Olszanski AJ.

Expert Opin Drug Metab Toxicol · review; journal article · DOI 10.1517/17425255.2012.652947

Bibliografisk träff 2011-12-15

Axitinib modulates hypoxia-induced blood-retina barrier permeability and expression of growth factors.

Kernt M, Thiele S, Liegl RG, Kernt B, Eibl K, Haritoglou C, Ulbig MW, Kampik A.

Growth Factors · journal article · DOI 10.3109/08977194.2011.639300

Bibliografisk träff 2011-12-15

Meta-analysis of contribution of genetic polymorphisms in drug-metabolizing enzymes or transporters to axitinib pharmacokinetics.

Brennan M, Williams JA, Chen Y, Tortorici M, Pithavala Y, Liu YC.

Eur J Clin Pharmacol · meta-analysis; research support, non-u.s. gov't; journal article · DOI 10.1007/s00228-011-1171-8

Bibliografisk träff 2011-06-14

Phase I study of axitinib (AG-013736) in combination with gemcitabine in patients with advanced pancreatic cancer.

Spano JP, Moore MJ, Pithavala YK, Ricart AD, Kim S, Rixe O.

Invest New Drugs · research support, non-u.s. gov't; clinical trial, phase i; journal article · DOI 10.1007/s10637-011-9697-2

Bibliografisk träff 2011-02-08

Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients.

Fujiwara Y, Kiyota N, Chayahara N, Suzuki A, Umeyama Y, Mukohara T, Minami H.

Invest New Drugs · research support, non-u.s. gov't; research-article; clinical trial, phase i; journal article · DOI 10.1007/s10637-011-9637-1

Bibliografisk träff 2010-08-26

Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers.

Pithavala YK, Tong W, Mount J, Rahavendran SV, Garrett M, Hee B, Selaru P, Sarapa N, Klamerus KJ.

Invest New Drugs · research support, non-u.s. gov't; research-article; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1007/s10637-010-9511-6